Jefferies Upgrades Pediatrix Medical Group (MD) to Buy

Jefferies analyst Jack Slevin upgraded Pediatrix Medical Group (NYSE: MD) from Hold to Buy with a price target of $14.00 (from $8.00).

The analyst said: "No longer the roll-up growth story of the early 2000s, MD's multi-yr simplification effort - finally - positions it for a return to its roots as a hospital-based pediatrics business & to recapture its place as one of the best FCF stories in HC Svcs, growing LSD% org. A clean B/S (<2x) and depressed valn (~ 7x PE) could see FCF put toward share repurchase and accelerate EPS growth to +DD% to drive a re-rating. PT $14, ~ 9x PE. "

For an analyst ratings summary and ratings history on Pediatrix Medical Group click here. For more ratings news on Pediatrix Medical Group click here.

Shares of Pediatrix Medical Group closed at $10.51 yesterday.

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• Smith-Midland receives Nasdaq notice for late quarterly filing
• Redwire Defense wins $15.9M Army contract for drone systems